Abstract:What is known and Objective: Cytochrome P450 2C19 (CYP2C19) and CYP2D6 are important xenobiotic metabolic enzymes and both show considerable genetic variability between Orientals and Caucasians. There are known marked heterogeneity in susceptibility to various cancers and hypertension among Chinese Mongolian, Hui and Han ethnic groups, but the molecular mechanisms are unknown. Our objective was to investigate the patterns of distribution of CYP2C19 and CYP2D6 polymorphisms among healthy Chinese subjects to determine whether any observed inter-ethnic variability might be worth further investigation as possible contributors to the known differences in disease prevalence. Methods: Blood samples were collected from 454 unrelated Chinese healthy subjects (214 Han, 111 Hui, 129 Mongolian) for genotyping analysis. The single nucleotide polymorphisms (SNPs) CYP2C19*2 (681G>A in exon 5), CYP2C19*3 (636G>A in exon 4) and CYP2D6*10 (188C>T in exon 1) were determined by the polymerase chain reactionrestriction fragment length polymorphism (PCR-RFLP) method. Results and Discussion: Significantly higher frequencies of the CYP2C19 poor metabolic genotypes were observed in Chinese Han (18.7%), Chinese Hui (25.0%) and Chinese Mongolian (10.9%) subjects than has been reported for Caucasians (1.73.0%, P < 0.01). The prevalent defective allele CYP2C19*2 occurred more frequently in both Chinese Hui (32.4%) and Han (29.7%) than in Chinese Mongolian (18.2%, P < 0.01) subjects. The CYP2C19*2 and CYP2C19*3 defective alleles were significantly more frequent in Chinese Han and Chinese Hui ethnic groups than have been reported for Caucasians (11.116.3% and 00.2%, P < 0.01). CYP2D6*1/*10 heterozygotes and CYP2D6*10/*10 homozygotes were observed more frequently in Chinese Han (43.1% and 27.2%), Hui (40.6% and 30.7%) and Mongolian subjects (31.3% and 9.6%, both P < 0.01) than have been reported for Caucasians (5.5% and 0.3%, P < 0.01). In Chinese Mongolians, the CYP2D6*10 allele occurred at a frequency (25.2%, P < 0.01) intermediate between those reported for Caucasians and the other two Chinese ethnic populations. What is new and Conclusions: This is first report of interethnic differences in frequencies of functional CYP2C19 and CYP2D6 genes among Chinese Mongolian, Hui and Han populations. These differences may be important in explaining reported inter-ethnic differences in disease prevalence and response to drugs.

Identification of CYP2D6 Impaired Functional Alleles in Mexican Americans.

Identification and Functional Assessment of EightCYP3A4Allelic Variants39–46Detected in the Chinese Han Population

The Identification of Novel CYP2D6 Variants in US Hmong: Results From Genome Sequencing and Clinical Genotyping

In Vitro Functional Assessment of 22 Newly Identified CYP2D6 Allelic Variants in the Chinese Population.

Frequency of CYP2D610 and 14 Alleles and Their Influence on the Metabolic Activity of CYP2D6 in a Healthy Chinese Population

In vivo characterization of CYP2D612, 29 and *84 using dextromethorphan as a probe drug: a case report

Distribution of CYP2D6 and CYP2C19 polymorphisms associated with poor metabolizer phenotype in five Amerindian groups and western Mestizos from Mexico

Correlation of Genetic Polymorphism of Cytochrome P4502D6 with Dextromethorphan Oxidative Metabolism in Chinese.

A Familial Study of Cytochrome P450 2D6(CYP2D6) Deficient Alleles

Functional Characterization of Cyp2d6 Novel Allelic Variants Identified in the Chinese Han Population

Allele frequency distribution of CYP2C9 2 and CYP2C9 3 polymorphisms in six Mexican populations

Identification And Functional Characterization Of New Potentially Defective Alleles Of Human Cyp2c19

Investigation of the Differences in the Pharmacokinetics of CYP2D6 Substrates, Desipramine, and Dextromethorphan in Healthy African Subjects Carrying the Allelic Variants CYP2D617 and CYP2D629, When Compared with Normal Metabolizers

[Distinguishing CYP2D6 Homozygous and Heterozygous Extensive Metabolizers by Dextromethorphan Phenotyping].

Genetic variations of human CYP2D6 in the Chinese Han population.

The Cytochrome P450 2D6 (CYP2D6) Enzyme Polymorphism: Screening Costs and Influence on Clinical Outcomes in Psychiatry

Identification and Functional Assessment of Eight CYP3A4 Allelic Variants 39-46 Detected in the Chinese Han Population

Effects of 22 Novel CYP2D6 Variants Found in the Chinese Population on the Bufuralol and Dextromethorphan Metabolisms in Vitro

Identification and in vitro functional assessment of 10 CYP2C9 variants found in Chinese Han subjects

Discovery of New Potentially Defective Alleles of Human Cyp2c9

Differences in Genotype and Allele Frequency Distributions of Polymorphic Drug Metabolizing Enzymes CYP2C19 and CYP2D6 in Mainland Chinese Mongolian, Hui and Han Populations